MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Prostate
Clovis Oncology, Inc. (NASDAQ: CLVS)
Organization & Developments: Clovis Oncology
Parents
Clovis Oncology, Inc. (NASDAQ: CLVS)
Children
2011: The company has not yet generated any revenue.
2017: VA_65--Clovis Oncology, Inc. 65IB
2018: Clovis Oncology: Some Positives Emerge_seekingalpha.com
2018: Clovis Pops After Ovarian Cancer Drug Gets FDA Win; Tesaro Topples
2019: Clovis Oncology Suffers Setback, But Additional Options Remain_seekingalpha.com
2019: Clovis Oncology: Best In Class_seekingalpha.com
2019: Clovis Oncology: Debating On Doubling Down Or Ditching_seekingalpha.com
2019: Clovis: Evaluating The Prospect Of The BMS Acquisition_seekingalpha.com
2019: Clovis: Market Valuation Is Still Far From Intrinsic Value_seekingalpha.com
2020: Clovis Oncology: Cash Position Is Tight, We Question Management's Guidance
2020: Clovis Oncology: Reloading Before And After Q3 Earnings For The Long Term
2020: Targeting A 50% Return In Clovis Oncology
2021: Clovis Oncology Stock: Only Glimmers Of Hope
2021: Clovis Oncology: Another Upcycle Coming
2021: Clovis Oncology: Finally Green Shoots May Be On The Horizon
2021: Clovis Oncology: Recent Rally Already Has Me Changing My Game Plan
2022: Clovis files for bankruptcy, will keep operating and plans to sell pipeline asset to Novartis
2022: Clovis Oncology: Looking Like An Acquisition Target After Recent Company Updates_ seekingalpha.com
2022: Troubled Clovis telegraphs bankruptcy amid FDA hardball on key cancer drug, difficulty in fundraising
Jumps
*Key People: Clovis Oncology
Finance & Acquisition: Clovis Oncology